Vertex Pharmaceuticals

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

Field	Value
Representation	alpha-profile-markdown-v3
Protocol	Alpha Governance Facts Protocol 0.1
Schema	alpha.governance.entity.public.v1
Record version	public-1
Canonical entity	alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9
Entity type	Company
Canonical URL	https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma
Publication	PUBLISHED
Verification	source_reported
Verification schema	alpha-verification-states-v1
Ownership	unclaimed
Published claims	30
Claims under review	1
Evidence records	14
Conflicts	0
Conflicts in internal review	0
Observed	2026-09-13T04:45:02.867545+00:00
Last reviewed	2026-09-13T04:45:02.867545+00:00

Identity

Legal name: VERTEX PHARMACEUTICALS INC / MA
Display name: Vertex Pharmaceuticals

Leadership

Jeffrey M. Leiden: Chair. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:3.
Alan Garber: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:4.
Bruce Sachs: Lead Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:5.
Diana McKenzie: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:6.
Jennifer Schneider: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:7.
Lloyd Carney: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:8.
Michel Lagarde: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:9.
Nancy Thornberry: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:9.
Reshma Kewalramani: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:5.
Sangeeta Bhatia: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:10.
Suketu Upadhyay: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:11.
Amit K. Sachdev, J.D.: Executive Vice President, Chief Patient and External Affairs Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Charles F. Wagner, Jr.: Executive Vice President, Chief Operating and Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Craig B. Thompson, M.D.: Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Duncan J. McKechnie: Executive Vice President, Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
E. Morrow Morrey Atkinson, III, Ph.D.: Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Jonathan Biller, J.D.: Executive Vice President, Chief Legal Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Kristen C. Ambrose, CPA: Senior Vice President, Chief Accounting Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Mark Bunnage, D.Phil: Executive Vice President, Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Ourania Nia Tatsis, Ph.D.: Executive Vice President, Chief Regulatory and Quality Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.
Reshma Kewalramani, M.D.: Chief Executive Officer and President. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12.

Roles

PUBLISHED

Governance

NOT_ASSERTED

Board committees

PUBLISHED

Financials

NOT_ASSERTED

Workforce

NOT_ASSERTED

Market and index context

S&P 500 (SPX). Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:13.
Nasdaq-100 (NDX). Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:14.

Legal Name

VERTEX PHARMACEUTICALS INC / MA. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1.

Headquarters

US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1.

Official Website

https://www.vrtx.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:2.

Published Fact

US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1.
MA. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1.
Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1.
https://www.vrtx.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:2.

Coverage states

Field	Value
Identity	PUBLISHED
Business	PUBLISHED
Leadership	PUBLISHED
Board and committees	PUBLISHED
Governance	NOT_ASSERTED
Financials	NOT_ASSERTED
Workforce	NOT_ASSERTED
Ownership	NOT_ASSERTED
Ratings	NOT_PUBLISHED
Market and index context	PUBLISHED

Public sources

alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:1: Alpha canonical company public projection.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:2: VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13).
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:3: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:4: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:5: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:6: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:7: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:8: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:9: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:10: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:11: Vertex Pharmaceuticals Incorporated director board source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:12: VRTX executive roster source.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:13: S&P 500.
alpha:evidence:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:14: Nasdaq-100.

Rights

Field	Value
public_retrieval	allowed
agent_retrieval	allowed
redistribution	not_granted
model_training	not_granted
commercial_use	not_specified
relationship_pathfinding	not_granted
direct_contact	not_granted

Limitations

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
Only explicitly published canonical company identity and current confirmed public roles are included.
Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations

Canonical profile
Public Markdown
Public JSON
JSON-LD
MCP resource: alpha://companies/vertex-pharmaceuticals-inc-ma at https://mcp.alpha.ac/mcp